ASCO 2022 Conference Coverage
A

Lecture Summary - ASCO 2022 Analysis of Patients With Relapsed SCLC Receiving Single-Agent Lurbinectedin in the Phase 3 ATLANTIS Trial

By ASCO 2022 Conference Coverage FEATURING Alejandro Navarro
By ASCO 2022 Conference Coverage FEATURING Alejandro Navarro
16 views
June 14, 2022
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
25:18
Janakiraman Subramanian

Updates in Small Cell Lung Carcinoma

18:35
2023 Evolution Conference

Recent Updates in SCLC

Feat. S. Kazmi
10:49
Niels Reinmuth

CASPIAN Trial: Clinical Implications of a 3-Year OS Update of Durval…

17:09
Stanford Medicine

New Drugs for Small Cell Lung Cancer

Feat. M. Das
07:17
Misty Shields

The Importance of Staying on Therapy for SCLC to Achieve Optimal Ben…

22:11
Insights from ELCC 2024

ELCC 2024 Insights: "Recent Advances and Challenges - Non-IO Ap…

Feat. M. Früh
04:18
Integrity Continuing Education

Advancing Care for Patients With SCLC

Feat. N. Florez, E. Rodriguez, C. Smith
10:16
Jerome Goldschmidt

National Platinum Chemo Shortages: Impact on Lung Cancer Treatment a…

08:53
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "CASPIAN Study Phase 3 Updates: The Progno…

Feat. A. Ganti
14:25
Alejandro Navarro

Dissecting SKYSCRAPER-02 Trial - TIGIT Story: From Hope to Nihilism

28:49
European School of Oncology

Management of SCLC: Guidelines ESMO & NCCN

Feat. A. Passaro
05:13
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 3 LAGOON Study - Lurbinectedin Al…

Feat. B. Besse
12:25
Lowell Hart

Burden of Chemo-Induced Myelosuppression Among Patients With ES-SCLC…

18:08
OncoAlert

Recent Advances in SCLC

Feat. J. Naidoo
19:22
Northwell Health

Current Treatment Landscape in SCLC

Feat. N. Seetharamu
04:25
Total Health

LS-SCLC Updates - 2023 ASCO® Direct Philadelphia

Feat. J. Bauman
22:38
Ivo Abraham

Trilaciclib and the Economic Value of Multilineage Myeloprotection F…

04:05
ASCO 2022 Conference Coverage

ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Study of 1L Vibostolim…

Feat. J. Sands
16:40
Total Health

Emerging Approaches to Small Cell Lung Cancer

Feat. J. Rotow
06:08
GRACE

ASCO® 2023 Insights: "Emerging Treatment Options for Patients W…

Feat. J. West, C. Lovly, A. Addeo